NEW YORK, NY / ACCESSWIRE / April 23, 2020 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the court. Further details about the cases can be found at the links provided. There is no cost or obligation to you.
BDX Shareholders Click Here: https://www.zlk.com/pslra-1/becton-dickinson-company-loss-form?prid=6149&wire=1
GOSS Shareholders Click Here: https://www.zlk.com/pslra-1/gossamer-bio-inc-loss-form?prid=6149&wire=1
BBBY Shareholders Click Here: https://www.zlk.com/pslra-1/bed-bath-beyond-inc-loss-form?prid=6149&wire=1
* ADDITIONAL INFORMATION BELOW *
Becton Dickinson & Company (NYSE:BDX)
BDX Lawsuit on behalf of: investors who purchased November 5, 2019 - February 5, 2020
Lead Plaintiff Deadline : April 27, 2020
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/becton-dickinson-company-loss-form?prid=6149&wire=1
According to the filed complaint, during the class period, Becton Dickinson & Company made materially false and/or misleading statements and/or failed to disclose that: (1) certain of Becton's Alaris infusion pumps experienced software errors and alarm prioritization issues; (2) as a result, the Company was investing in remediation efforts to address these product issues, rather than a software upgrade to "make enhancements;" (3) the Company was reasonably likely to face regulatory delays in connection with the software remediation; (4) as a result of the foregoing, Becton was reasonably likely to recall certain of its Alaris infusion pumps; and (5) as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially false and/or misleading and/or lacked a reasonable basis.
Gossamer Bio, Inc. (NASDAQ:GOSS)
GOSS Lawsuit on behalf of: investors who purchased common stock between February 8, 2019 and December 13, 2019 and/or who acquired Gossamer shares pursuant or traceable to Gossamer's documents issued in connection with its February 8, 2019 initial public offering.
Lead Plaintiff Deadline : June 2, 2020
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/gossamer-bio-inc-loss-form?prid=6149&wire=1
The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose: (1) the reasons for Gossamer's GB001 trial failures; (2) the purported clinical validation of Novartis' oral DP2 antagonist; and (3) that, as a result of the foregoing, Defendants' public statements were materially false and misleading at all relevant times.
Bed Bath & Beyond Inc. (NASDAQ:BBBY)
BBBY Lawsuit on behalf of: investors who purchased October 2, 2019 - February 11, 2020
Lead Plaintiff Deadline : June 15, 2020
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/bed-bath-beyond-inc-loss-form?prid=6149&wire=1
According to the filed complaint, during the class period, Bed Bath & Beyond Inc. made materially false and/or misleading statements and/or failed to disclose that: (1) due to "aggressive disposition of inventory," the Company lacked sufficient inventory in key categories to support holiday sales; (2) the Company's internal control over inventory levels and financial reporting was not effective; (3) as a result of the foregoing, the Company was likely to experience reduced sales; and (4) as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects, were materially misleading and/or lacked a reasonable basis.
You have until the lead plaintiff deadlines to request that the court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.
Levi & Korsinsky is a nationally recognized firm with offices in New York, California, Connecticut, and Washington D.C. The firm's attorneys have extensive expertise and experience representing investors in securities litigation and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
55 Broadway, 10th Floor
New York, NY 10006
jlevi@levikorsinsky.com
Tel: (212) 363-7500
Fax: (212) 363-7171
www.zlk.com
SOURCE: Levi & Korsinsky, LLP
View source version on accesswire.com:
https://www.accesswire.com/586616/CLASS-ACTION-UPDATE-for-BDX-GOSS-and-BBBY-Levi-Korsinsky-LLP-Reminds-Investors-of-Class-Actions-on-Behalf-of-Shareholders
